CollPlant Biotechnologies (CLGN) Finished Goods (2022 - 2025)

CollPlant Biotechnologies' Finished Goods history runs 4 years deep, the most recent figure standing at $290000.0 for Q4 2025.

• Quarterly Finished Goods rose 88.31% year-over-year to $290000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $290000.0 (up 88.31% YoY) and the FY2025 annual result came in at $290000.0, up 88.31% from the prior year.
• Finished Goods was $290000.0 for Q4 2025 at CollPlant Biotechnologies, up from $154000.0 in the prior quarter.
• Across five years, Finished Goods topped out at $549000.0 in Q4 2022 and bottomed at $154000.0 in Q4 2024.
• A 4-year average of $383500.0 and a median of $415500.0 in 2023 frame the typical range for Finished Goods.
• Annual changes were most pronounced in 2024 — Finished Goods sank 71.53% — and 2025, when it soared 88.31%.
• CollPlant Biotechnologies' Finished Goods stood at $549000.0 in 2022, then dropped by 1.46% to $541000.0 in 2023, then sank by 71.53% to $154000.0 in 2024, then surged by 88.31% to $290000.0 in 2025.
• Business Quant data shows CLGN's Finished Goods at $290000.0 in Q4 2025, $154000.0 in Q4 2024, and $541000.0 in Q4 2023.